Sonoma Pharmaceuticals, Inc.
(NASDAQ : OCLS)

( )
OCLS PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
SAVACassava Sciences, Inc. -2.16%49.780.0%$741.38m
GWPHGW Pharmaceuticals Plc -0.40%214.006.1%$392.07m
HZNPHorizon Therapeutics Plc 0.00%90.575.6%$194.42m
JAZZJazz Pharmaceuticals Plc 0.00%170.742.3%$191.25m
VRXValeant Pharmaceuticals International, Inc. -1.05%30.9714.1%$182.23m
BHCBausch Health Cos., Inc. -1.05%30.970.0%$140.24m
CTLTCatalent, Inc. 0.15%112.422.1%$113.99m
ICLRICON plc 0.00%184.444.2%$87.59m
ARGXargenx SE -0.07%339.240.0%$83.79m
TNXPTonix Pharmaceuticals Holding Corp. 0.82%1.230.2%$70.63m
ZYNEZynerba Pharmaceuticals, Inc. -2.47%4.356.0%$57.01m
PRGOPerrigo Co. Plc 0.10%40.826.8%$53.61m
AMRNAmarin Corp. Plc 0.00%6.951.5%$53.13m
UTHRUnited Therapeutics Corp. 0.00%168.8014.1%$46.29m
PBHPrestige Consumer Healthcare, Inc. 0.14%41.834.0%$43.24m

Company Profile

Sonoma Pharmaceuticals, Inc. engages in identifying, developing, and commercializing therapies for chronic skin conditions. The company offers solutions in dermatology, animal healthcare, and advanced tissue care product areas. Its products target skin diseases including acne, atopic dermatitis, scarring, infections, itch, pain, and harmful inflammatory responses. The company was founded by Hojabr Alimi and Linda Alimi in April 1999 and is headquartered in Woodstock, GA.